慢性心力衰竭的处理近年发生了显著的变化.以往多采用强心甙、利尿剂、限制钠盐等措施,近年又选用血管扩张剂,但仍有许多病人疗效不够满意.况且强心甙治疗指数低,因此,人们致力于寻找新型的正性变力作用药物.氨利酮系一种双吡啶类衍生物,第一个非强心甙,非交感胺类变力药物,兼有正性变力和血管扩张作用,能有效地改善心脏功能. In recent years, the use of cardiac glycosides, diuretics, sodium and other measures to limit the use of vasodilators in recent years, but there are still many patients are not satisfied with the efficacy. And cardiac glycosides treatment index Low, therefore, people are committed to looking for a new type of positive variable action drugs.Andronicone is a bipyridine derivatives, the first non-cardiac glycosides, non-sympathetic amines variable drugs, both positive Force and vasodilator effect, can effectively improve heart function.